Aurinia Pharmaceuticals (AUPH) Change in Inventory (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Change in Inventory of $720000.0 for Q1 2026, down 19.73% on a QoQ basis from $897000.0 in Q4 2025, and down 89.67% year-over-year from $7.0 million in Q1 2025.
Aurinia Pharmaceuticals (AUPH) Change in Inventory (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals' Change in Inventory history runs 7 years deep, the most recent figure standing at $720000.0 for Q1 2026.
- Quarterly Change in Inventory fell 89.67% year-over-year to $720000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $215000.0 (down 96.66% YoY) and the FY2025 annual result came in at $6.5 million, up 1454.72% from the prior year.
- Change in Inventory was $720000.0 for Q1 2026 at Aurinia Pharmaceuticals, down from $897000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $7.0 million in Q1 2023 and bottomed at -$1.7 million in Q3 2025.
- A 5-year average of $1.9 million and a median of $614000.0 in 2022 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 12341.07% in 2025, while the deepest fall reached 1130.22% in 2025.
- Aurinia Pharmaceuticals' Change in Inventory stood at $614000.0 in 2022, then surged by 1021.34% to $6.9 million in 2023, then tumbled by 92.53% to $514000.0 in 2024, then jumped by 74.51% to $897000.0 in 2025, then fell by 19.73% to $720000.0 in 2026.
- Business Quant data shows AUPH's Change in Inventory at $720000.0 in Q1 2026, $897000.0 in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.68 Bn | 71.20 Mn | 720,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720,000.00 |
| Mar 31, 2026 | 720,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | -1.71 Mn |
| Sep 30, 2025 | -1.71 Mn |
| Jun 30, 2025 | 308,000.00 |
| Jun 30, 2025 | 308,000.00 |
| Mar 31, 2025 | 6.97 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Dec 31, 2024 | 514,000.00 |
| Dec 31, 2024 | 514,000.00 |
| Sep 30, 2024 | -139,000.00 |
| Sep 30, 2024 | -139,000.00 |
| Jun 30, 2024 | -908,000.00 |
| Jun 30, 2024 | -908,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 6.89 Mn |
| Dec 31, 2023 | 6.89 Mn |